Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

NCT03566693

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Keck School of Medicine @ USC Los Angeles, California, United States
  • Scripps Whittier Diabetes Institute San Diego, California, United States
  • Emory University Atlanta, Georgia, United States
  • Northwestern Memorial Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

NCT02607306

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Adachi-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Akita-shi, Akita, Japan
  • Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan
  • Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan
View all 76 locations
View Trial Details
Completed

A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

NCT02911948

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan
  • Novo Nordisk Investigational Site Chigasaki-shi, Kanagawa, Japan
  • Novo Nordisk Investigational Site Chitose, Hokkaido, Japan
  • Novo Nordisk Investigational Site Chiyoda-ku, Tokyo, Japan
View all 38 locations
View Trial Details
Completed

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

NCT03951805

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Lancaster, California, United States
  • Novo Nordisk Investigational Site Roswell, Georgia, United States
  • Novo Nordisk Investigational Site Statesboro, Georgia, United States
View all 43 locations
View Trial Details
Completed

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

NCT03751657

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Novo Nordisk Investigational Site Lancaster, California, United States
  • Novo Nordisk Investigational Site Ventura, California, United States
  • Novo Nordisk Investigational Site Walnut Creek, California, United States
  • Novo Nordisk Investigational Site Roswell, Georgia, United States
View all 49 locations
View Trial Details

Related conditions